Statin use and risk of dementia or Alzheimer's disease: a systematic review and meta-analysis of observational studies.

These results confirm the absence of a neurocognitive risk associated with statin treatment and suggest a potential favourable role of statins. Randomized clinical trials with an ad hoc design are needed to explore this potential neuroprotective effect.